Comments
This is to inform you that revised Financial Results for the year ended on March 2018 along with reconciliation of Net Profit/losses and Equity Shares as previously reported on account of transition from the previous Indian GAAP to IND AS for the year ended March 2017 now been enclosed.
Pdf Link: Medicamen Biotech Ltd. - Revised Financial Results For The Year Ended March 2018.
Source : BSE - www.bseindia.com
Comments
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.